Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention.
Xie JY, De Felice M, Kopruszinski CM, Eyde N, LaVigne J, Remeniuk B, Hernandez P, Yue X, Goshima N, Ossipov M, King T, Streicher JM, Navratilova E, Dodick D, Rosen H, Roberts E, Porreca F. Xie JY, et al. Among authors: eyde n. Cephalalgia. 2017 Jul;37(8):780-794. doi: 10.1177/0333102417702120. Epub 2017 Apr 4. Cephalalgia. 2017. PMID: 28376659 Free PMC article.
Capturing the aversive state of cephalic pain preclinically.
De Felice M, Eyde N, Dodick D, Dussor GO, Ossipov MH, Fields HL, Porreca F. De Felice M, et al. Among authors: eyde n. Ann Neurol. 2013 Aug;74(2):257-65. doi: 10.1002/ana.23922. Epub 2013 Sep 10. Ann Neurol. 2013. PMID: 23686557 Free PMC article.
Efficacy of (S)-Lacosamide in preclinical models of cephalic pain.
Moutal A, Eyde N, Telemi E, Park KD, Xie JY, Dodick DW, Porreca F, Khanna R. Moutal A, et al. Among authors: eyde n. Pain Rep. 2016 Jun;1(1):e565. doi: 10.1097/PR9.0000000000000565. Pain Rep. 2016. PMID: 27917413 Free PMC article.
Corrigendum: A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors.
Iadonato S, Ovechkina Y, Lustig K, Cross J, Eyde N, Frazier E, Kabi N, Katz C, Lance R, Peckham D, Sridhar S, Talbaux C, Tihista I, Xu M, Guillaudeux T. Iadonato S, et al. Among authors: eyde n. Front Immunol. 2024 Jan 23;15:1365240. doi: 10.3389/fimmu.2024.1365240. eCollection 2024. Front Immunol. 2024. PMID: 38322267 Free PMC article.
A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors.
Iadonato S, Ovechkina Y, Lustig K, Cross J, Eyde N, Frazier E, Kabi N, Katz C, Lance R, Peckham D, Sridhar S, Talbaux C, Tihista I, Xu M, Guillaudeux T. Iadonato S, et al. Among authors: eyde n. Front Immunol. 2023 Dec 12;14:1311658. doi: 10.3389/fimmu.2023.1311658. eCollection 2023. Front Immunol. 2023. PMID: 38152397 Free PMC article.